Prostate-specific membrane antigen (PSMA) is a characteristic biomarker for prostate cancer cells (Wester and Schottelius, 2019), and enhanced expression has also been observed in tumor vasculature. This evidence concerns the gene FOLH1 and prostate carcinoma.